We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > FDA

News List

Aurobindo Pharma gets US FDA nod for its anti-epileptic drug and to acquire Portugal’s Generis for € firstwordpharma
January 09, 2017
Aurobindo Pharma has been granted final FDA approval to launch a generic version of HQ Specialty Pharma's epilepsy drug levetiracetam, livemint.com reported, Aurobindo Pharma to acquire Portugal’s Generis for €135 million.
FDA Approves Supplemental New Drug Applications to Include New Data in Product Labels for Synjardy®, americanpharmaceuticalreview
January 06, 2017
The U.S. Food and Drug Administration has approved supplemental New Drug Applications for three type 2 diabetes medicines within the empagliflozin family to include data from the landmark EMPA-REG OUTCOME® trial.
FDA grants priority review for Bayer’s liver cancer treatment europeanpharmaceuticalreview
January 05, 2017
The US Food and Drug Administration (FDA) has granted priority review status for the supplemental new drug application for Stivarga (regorafenib, Bayer), as a second line systemic treatment of patients with hepatocellular carcinoma (HCC) in the US.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 366 367 Next page